Partnering with GammaDelta Therapeutics
GammaDelta Therapeutics is building partnerships with prestigious research institutions, experts in immune therapy and life science investors.
Additional areas of interest
Whereas we are focussed on exploring Vδ1+ T cell based cell therapy of cancer, we have gained tremendous insight into Vδ1+ T cell cell biology through our own studies and from our collaborators. These insights have resulted in identification of a number of targets for exploitation via molecular agents. We are actively pursuing such targets via collaboration with Adaptate Biotherapeutics and other external third parties.